Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADD-AMI: Amiloride Natriuretic Effect in Hypertension
NCT06416735Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Sep 2018
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amiloride in essential hypertension, sponsored by IRCCS Ospedale San Raffaele. Started Sep 2018; status: completed.
02
Drugs
amiloride
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT06416735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06416735.